ClinicalTrials.gg
BiologicalDrug

Oregovomab clinical trials

Also written MAb-B43.13.

studies test it
15
open now
0
in phase 3
2
first study started
1998

How each study uses oregovomab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Oregovomab
15
OvaRex
3
Monoclonal antibody B43.13
2

Development codes

MAb-B43.13
4

Studies by the year they started

15 studies that test it; most in 1998 (2)

Studies that test oregovomab, by start year
YearStudies
19982
20001
20022
20041
20121
20131
20172
20202
20211
20221
20231

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
12
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 12 · Other 3

CanariaBio Inc. (5) · Unither Pharmaceuticals (4) · National Cancer Centre, Singapore (2) · AltaRex (2) · University of Nebraska (1) · Quest PharmaTech Inc. (1)

Often tested with

Tested in the same studies.

Bevacizumab (1) · Paclitaxel (1) · Carboplatin (1) · Nelfinavir (1) · Poly ICLC (1) · Antineoplastic Agents (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test oregovomab, phase 3 first.

Studies

Open first, then newest update. How each study uses oregovomab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 15

Given beside what is tested · 1 — oregovomab is usual care or a partner of the new treatment

Codes

What other systems call oregovomab · ClinicalTrials.gg INT004006

  • MeSH (NLM) C107428oregovomabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) HX101E7L6SOREGOVOMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q7101491OregovomabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1784OregovomabOne source FDA
  • DrugBank DB04964One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.